Pharmaceutical News

RSS

Research on psychedelics could lead to new treatments for mental illness

One in five U.S. adults will experience a mental illness in their lifetime, according to the National Alliance of Mental Health. But standard treatments can be slow to work and cause side effects.

24 Nov 2021

Can dexamethasone reduce prolonged COVID-19 symptoms?

A new study assesses hospitalized patients after recovering from COVID-19 by comparing the individuals before and after being treated with dexamethasone.

24 Nov 2021

Common heart burn medication could lessen the effectiveness of lung cancer treatment

A common medication used to treat reflux, heart burn and ulcers could lessen the effectiveness of lung cancer immunotherapy drugs, according to new Flinders University research.

24 Nov 2021

How does penicillin work?

In this interview, we spoke to Dr. Bartlomiej Salamaga about his latest research that discovered how penicillin works in the body.

24 Nov 2021

Mouthwash containing an antiviral phthalocyanine derivative shortens hospitalizations due to COVID-19

In a study published in the journal Scientific Reports, a research group from Brazil showed how antiviral anionic phthalocyanine derivative used in a mouthwash protocol may not only reduce the symptoms of coronavirus disease (COVID-19), but also hamper the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

23 Nov 2021

Anti-inflammatory drug used to treat gout does not reduce the risk of COVID-19 mortality

Colchicine, a cheap anti-inflammatory drug normally used to treat gout, doesn't lessen COVID-19 severity or stave off the risk of death from the infection in hospital patients, finds a pooled analysis of the available evidence, published in the open access journal RMD Open.

23 Nov 2021

Oral Hsp90 inhibitor SNX-5422 interferes with replication machinery of SARS-CoV-2

A new study evaluates the efficacy of SNX-5422 as a post-exposure prophylactic treatment.

23 Nov 2021

Antigenic cocktail produced in Nicotiana benthamian plant as a potential COVID-19 vaccine candidate

Scientists utilize N. benthamiana for producing the N-protein and an antigenic cocktail containing the N-protein and SARS-CoV-2 S RBD.

23 Nov 2021

Tobacco mosaic virus nanoparticle-based novel COVID-19 vaccine candidate

Scientists generate a VLP type NP platform made of recombinant viral antigens conjugated with TMV virions.

23 Nov 2021

Inactivated virion-based vaccine confers robust cell-mediated immunity against major SARS-CoV-2 variants

Indian researchers determine the magnitude, quality, and persistence of cellular and humoral memory responses after vaccination with BBV152/Covaxin.

23 Nov 2021

Success of covid antiviral pills hinges on access to speedy and accurate tests

Within a few weeks, perhaps before many Americans finish decorating for the holidays, the U.S. could have access to a new antiviral pill from Merck expected to alter the deadly trajectory of the covid-19 pandemic — with a second option from Pfizer to follow shortly after.

22 Nov 2021

CoronaVac vaccine booster strengthens protection against SARS-CoV-2

In a recent study published on the preprint medRxiv* server, an international team of scientists tested CoronaVac as a booster shot and measured its effects on immunity. Their findings showed increases in neutralizing antibodies and T cell response.

21 Nov 2021

TXA drug has minimal impact in controlling blood loss in severely injured trauma patients

A recent study found that the drug tranexamic acid has minimal impact in controlling blood loss in severely injured trauma patients at the standard doses given, according to researchers at Washington University School of Medicine in St. Louis.

21 Nov 2021

A nasal COVID vaccine using a weakened influenza vector

The authors of a new study, published on the bioRxiv* preprint server, constructed a COVID-19 nasal vaccine candidate by inserting a gene encoding the receptor-binding domain (RBD) of the spike protein of SARS-CoV-2, named CA4-dNS1-nCoV-RBD (dNS1-RBD) in a live attenuated influenza virus (LAIV) vector.

18 Nov 2021

REGEN-COV is effective in preventing severe COVID-19 in immunocompromised individuals

A recent study assesses the efficacy of repeat doses of REGEN-COV in SARS-CoV-2-negative adults who were healthy or had chronic medical conditions.

18 Nov 2021

UQ strikes a deal with Canadian company to revolutionize the way patients take medical cannabis

The University of Queensland has struck a deal with Canadian health and wellness company PreveCeutical Medical which could revolutionize the way patients take medical cannabis.

18 Nov 2021

Antiretroviral drugs detected in drinking water

Years ago, there was a time that kids from a rural village in South Africa still wanted to swim in the rivers nearby. But when they got out of the water, those with sensitive skins would have the worst rash ever, says Prof Philiswa Nomngongo.

18 Nov 2021

Real-world effectiveness and safety of COVID-19 vaccines

A new study published in Infectious Diseases of Poverty aimed to systematically evaluate the effectiveness and safety of the COVID-19 vaccines in the real world as well as establish a reliable evidence-based basis to determine the actual protective effect of the COVID-19 vaccines, especially considering the new waves of infection brought about by the variants.

18 Nov 2021

Evidence of significantly greater protection against COVID from BNT162b2 boosters

In a new study, researchers from several British institutes estimated the effectiveness of booster vaccination against symptomatic COVID-19 in adults aged 50 years and older.

18 Nov 2021

Inhaled prostacyclin improves oxygenation in acute respiratory distress syndrome patients

The findings reveal that inhaled prostacyclin significantly improves oxygenation in ARDS patients who had COVID-19. The study is currently available on the medRxiv* preprint server.

17 Nov 2021

Pharmaceutical News

Research on psychedelics could lead to new treatments for mental illness

Can dexamethasone reduce prolonged COVID-19 symptoms?

Common heart burn medication could lessen the effectiveness of lung cancer treatment

How does penicillin work?

Mouthwash containing an antiviral phthalocyanine derivative shortens hospitalizations due to COVID-19

Anti-inflammatory drug used to treat gout does not reduce the risk of COVID-19 mortality

Oral Hsp90 inhibitor SNX-5422 interferes with replication machinery of SARS-CoV-2

Antigenic cocktail produced in Nicotiana benthamian plant as a potential COVID-19 vaccine candidate

Tobacco mosaic virus nanoparticle-based novel COVID-19 vaccine candidate

Inactivated virion-based vaccine confers robust cell-mediated immunity against major SARS-CoV-2 variants

Success of covid antiviral pills hinges on access to speedy and accurate tests

CoronaVac vaccine booster strengthens protection against SARS-CoV-2

TXA drug has minimal impact in controlling blood loss in severely injured trauma patients

A nasal COVID vaccine using a weakened influenza vector

REGEN-COV is effective in preventing severe COVID-19 in immunocompromised individuals

UQ strikes a deal with Canadian company to revolutionize the way patients take medical cannabis

Antiretroviral drugs detected in drinking water

Real-world effectiveness and safety of COVID-19 vaccines

Evidence of significantly greater protection against COVID from BNT162b2 boosters

Inhaled prostacyclin improves oxygenation in acute respiratory distress syndrome patients

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News